CK-2289 is an inhibitor of type III cyclic 35-adenosine monophosphate phosphodiesterase (PDE). CK-2289 can inhibit platelet aggregation and decreases mean arterial blood pressure. CK-2289 can be used for the research of cardiovascular disease, such as congestive heart failure[1].
Molecular Weight:
282.30
CAS Number:
[101183-99-7]
Formula:
C15H14N4O2
Target:
Phosphodiesterase (PDE)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
